The Virtual Hamilton FHT Pharmacist

Thursday, March 8, 2012

Subscribe to: Comments (Atom)

Annette's Phun Pharmacy Phacts - Narcotic Safety and Awareness Act
Clinical Aspects of Hypoglycemia in Diabetes – Consequences and Prevention
Approach to management of hyperglycemia Figure
Hyperuricemia and Gout

By: Annette Vedelago 1) Natural history of gout Unusual for gout to occur under age 30 in males or under age 50 in females Fou...
Ontario Narcotic Strategy - List of Drugs

By Mary Nelson
Folic acid 5mg & obesity (BMI>30kg/m2)

At the CDA 2011 conference, folic acid 5mg/d is recommended for patients with Type 2 DM and obesity > 30kg/m2. This is based on a theore...
ADA 2012 Part 1
Omega-3 Fatty Acids & CV outcomes in patients with dysglycemia

Clinical Question In patients at high risk for cardiovascular events and have impaired fasting glucose, impaired glucose tolerance, or diab...
Update on OxyContin & OxyNEO

Effective March 1, 2012 Purdue Pharma is withdrawing its current formulation of oxycodone controlled release tablet, OxyContin, and intro...
Update on Basal & Bolus Insulins

Quote of the Day “Everyone knows it requires brains to live long with diabetes, but to use insulin successfully requires more brains” ...

Hamilton FHT 2011. Watermark theme. Powered by Blogger.